B Cell Maturation Antigen Targeted CAR-T Cells in Treatment With Relapsed and Refractory Multiple Myeloma

NCT05150522 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma
Relapse Multiple Myeloma
Refractory Multiple Myeloma

Interventions

BIOLOGICAL: BCMA CAR-T cells

Sponsor

Shenzhen University General Hospital